Randomization of the Damaged Base-Capping Loop Rewires Substrate Specificity in Formamidopyrimidine–DNA Glycosylase
Biochemistry · 03.11.2026 · 65 (21) · 3419-3433
DOI: 10.1021/acs.biochem.6c00579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, online erschienen am 16.10.2026. Verfasst von Nikita A Bulgakov und 9 weiteren Autor:innen. Beteiligte Einrichtung: SB RAS Knorre Institute of Chemical Biology and Fundamental Medicine, 8 Lavrentieva Ave., Novosibirsk630090, Russia. Hauptthemen laut MEDLINE: DNA-Formamidopyrimidine Glycosylase, DNA Damage. Die Arbeit nennt 109 Literaturangaben. Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation, Ligue contre le Cancer du Grand-Ouest.
Abstract (Originalsprache)
Formamidopyrimidine–DNA glycosylase (Fpg) is a bacterial base excision repair enzyme that removes 8-oxoguanine (8-oxoG) and some other oxidatively damaged nucleobases from DNA. Fpg hydrolyzes the N-glycosidic bond of the damaged nucleotide and nicks DNA at the resulting apurinic/apyrimidinic (AP) site by β-elimination. Together with bacterial endonuclease VIII and eukaryotic homologues, more specific for damaged pyrimidines, Fpg belongs to a helix–two-turn–helix (H2TH) superfamily of DNA glycosylases. Crystal structures of Fpg reveal that the enzyme recognizes 8-oxoG by flipping it out of the DNA duplex and capping it with a flexible tetrapeptide loop. However, this loop is poorly conserved and contacts 8-oxoG only through the main-chain amides, raising questions about the enzyme specificity determinants. To clarify the mechanism of 8-oxoG recognition, we have produced and characterized five variants of Fpg from Lactococcus lactis with a randomized capping loop. All of these mutants were deficient in 8-oxoG repair, both in vitro and in the E. coli complementation assay, yet retained the ability to bind AP site-containing DNA, form a Schiff base covalent reaction intermediate, and catalyze β-elimination. The mutants were still active in the removal of 5-hydroxyuracil (OHU), an alternative Fpg substrate. All loop mutants showed relaxed opposite-base specificity, processing AP sites and OHU opposite either C or A. Thus, whereas the general architecture of the active site in H2TH DNA glycosylases is permissive for the excision of a wide range of oxidized bases, the capping loop endows Fpg with the specificity for its biologically relevant substrate, 8-oxoguanine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- SB RAS Knorre Institute of Chemical Biology and Fundamental Medicine, 8 Lavrentieva Ave., Novosibirsk630090, Russia.
- Novosibirsk State University, 2 Pirogova St., Novosibirsk630090, Russia.
- Centre de Biophysique Moléculaire, UPR4301 CNRS, 45071Orléans Cedex 2, France.
ORCID-Profile: Nikita A Bulgakov, Franck Coste, Victor M Golyshev, Alexander A Lomzov, Anna V Yudkina, Dmitry O Zharkov
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
- Ligue contre le Cancer du Grand-Ouest
Zitieren
APA
Bulgakov, N. A., Amanova, M. M., Endutkin, A. V., Makasheva, K. A., Coste, F., Castaing, B., Golyshev, V. M., Lomzov, A. A., Yudkina, A. V., & Zharkov, D. O. (2026). Randomization of the Damaged Base-Capping Loop Rewires Substrate Specificity in Formamidopyrimidine–DNA Glycosylase. Biochemistry, 65(21), 3419-3433. https://doi.org/10.1021/acs.biochem.6c00579
Vancouver
Bulgakov NA, Amanova MM, Endutkin AV, Makasheva KA, Coste F, Castaing B, et al. Randomization of the Damaged Base-Capping Loop Rewires Substrate Specificity in Formamidopyrimidine–DNA Glycosylase. Biochemistry. 2026;65(21):3419-3433. doi:10.1021/acs.biochem.6c00579
BibTeX
@article{Bulgakov2026,
author = {Bulgakov, Nikita A and Amanova, Margarita M and Endutkin, Anton V and Makasheva, Kristina A and Coste, Franck and Castaing, Bertrand and Golyshev, Victor M and Lomzov, Alexander A and Yudkina, Anna V and Zharkov, Dmitry O},
title = {Randomization of the Damaged Base-Capping Loop Rewires Substrate Specificity in Formamidopyrimidine–DNA Glycosylase},
journal = {Biochemistry},
year = {2026},
volume = {65},
number = {21},
pages = {3419--3433},
doi = {10.1021/acs.biochem.6c00579}
}
EUVIMED